21st Austria weekly - Valneva EVN 25/02/2022 [pic1]Valneva: Valneva SE an Austrian/French specialty vaccine company today announced that the Committee for Medicinal Products Human Use CHMP of European Medicines Agency EMA has provided initial assessment Valneva’s inactivated adjuvanted COVID-19

Related Keywords

Austria , Austrian , , European Medicines Agency , Committee For Medicinal Products Human Use , Medicinal Products , Human Use , South East Europe , Besuchen Sie , Ic1 Valneva , Valneva , Tse , Austrian French , Committee , Medicinal , Products , Human , Use , Chmp , European , Medicines , Agency , Fema , Valneva Amp Rsquo S , Covid 19 ,